Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol

INTRODUCTION: Community-acquired pneumonia (CAP) continues to be a major health problem worldwide and is one of the main reasons for prescribing antibiotics. However, the causative agent is often not identified, resulting in antibiotic overtreatment, which is a key driver of antimicrobial resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Abelenda-Alonso, Gabriela, Rombauts, Alexander, Gudiol, Carlota, Meije, Yolanda, Clemente, Mercedes, Ortega, Lucía, Ardanuy, Carmen, Niubó, Jordi, Padullés, Ariadna, Videla, Sebastian, Tebe, Cristian, Carratalà, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443276/
https://www.ncbi.nlm.nih.gov/pubmed/32819999
http://dx.doi.org/10.1136/bmjopen-2020-038957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443276/
https://www.ncbi.nlm.nih.gov/pubmed/32819999
http://dx.doi.org/10.1136/bmjopen-2020-038957

Ejemplares similares